Tilray Inc

NASDAQ:TLRY USA Drug Manufacturers - Specialty & Generic
Market Cap
$803.90 Million
Market Cap Rank
#8233 Global
#4196 in USA
Share Price
$6.90
Change (1 day)
+0.15%
52-Week Range
$0.36 - $13.94
All Time High
$214.06
About

Tilray Brands, Inc., a lifestyle consumer products company, engages in the research, cultivation, processing, and distribution of medical cannabis products in Canada, the United States, Europe, the Middle East, Africa, and internationally. The company operates through four segments: Beverage, Cannabis, Distribution, and Wellness. It also offers medical and adult-use cannabis products; resells and… Read more

Tilray Inc (TLRY) - Total Assets

Latest total assets as of November 2025: $2.93 Billion USD

Based on the latest financial reports, Tilray Inc (TLRY) holds total assets worth $2.93 Billion USD as of November 2025.

Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments.

Tilray Inc - Total Assets Trend (2012–2025)

This chart illustrates how Tilray Inc’s total assets have evolved over time, based on quarterly financial data. Explore and compare other companies by total assets.

Tilray Inc - Asset Composition Analysis

Current Asset Composition (May 2025)

Tilray Inc's total assets of $2.93 Billion consist of 32.5% current assets and 67.5% non-current assets.

Asset Category Amount (USD) % of Total Assets
Cash & Equivalents $0.00 10.5%
Accounts Receivable $166.71 Million 5.7%
Inventory $371.70 Million 12.8%
Property, Plant & Equipment $0.00 0.0%
Intangible Assets $29.40 Million 1.0%
Goodwill $1.03 Billion 35.5%

Asset Composition Trend (2012–2025)

This chart illustrates how Tilray Inc's asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution.

Key Asset Composition Facts

  • Current vs. Non-Current Assets: Tilray Inc's current assets represent 32.5% of total assets in 2025, a decrease from 100.0% in 2012.
  • Cash Position: Cash and equivalents constituted 10.5% of total assets in 2025, up from 6.9% in 2012.
  • Tangible vs. Intangible: Intangible assets (including goodwill) make up 36.0% of total assets, an increase from 0.0% in 2012.
  • Asset Diversification: The largest asset category is goodwill at 35.5% of total assets.

Tilray Inc Competitors by Total Assets

Key competitors of Tilray Inc based on total assets are shown below.

Company Country Total Assets
Swedish Orphan Biovitrum AB (publ)
PINK:BIOVF
USA $67.26 Billion
Dongwha Pharm.Co.Ltd
KO:000020
Korea ₩654.63 Billion
Shenzhen Neptunus Bioengineering Co Ltd
SHE:000078
China CN¥27.28 Billion
Yuhan Corp Preferred
KO:000105
Korea ₩3.05 Trillion
Anhui Fengyuan Pharmaceutical Co Ltd
SHE:000153
China CN¥4.97 Billion
Kotra Industries Bhd
KLSE:0002
Malaysia RM363.90 Million
Yuyu Pharma
KO:000220
Korea ₩202.42 Billion
Ildong Holdings Co Ltd
KO:000230
Korea ₩813.62 Billion

Tilray Inc - Asset Efficiency Metrics

Asset efficiency metrics measure how effectively a company uses its assets to generate revenue and profits. These indicators help investors evaluate management's ability to deploy capital efficiently.

Asset Turnover Ratio

Measures how efficiently a company uses its assets to generate sales

Historical Range: 0.10 - 0.42

Lower asset utilization - Tilray Inc generates 0.39x its asset value in annual revenue.

Return on Assets (ROA)

Measures how efficiently a company uses its assets to generate profits

Historical Range: -103.31% - 33.22%

Negative ROA - Tilray Inc is currently not profitable relative to its asset base.

Tilray Inc - Liquidity and Working Capital Analysis

Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.

Key Liquidity Metrics

Metric Current 1 Year Ago 5 Years Ago
Current Ratio 2.81 2.54 3.37
Quick Ratio 1.72 1.58 1.80
Cash Ratio 0.00 0.00 0.00
Working Capital $656.58 Million $ 599.78 Million $ 403.16 Million

Tilray Inc - Advanced Valuation Insights

This section examines the relationship between Tilray Inc's asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.

Key Valuation Metrics

Current Price-to-Book Ratio 0.55
Latest Market Cap to Assets Ratio 0.27
Asset Growth Rate (YoY) -50.8%
Total Assets $2.90 Billion
Market Capitalization $797.58 Million USD

Valuation Analysis

Below Book Valuation: The market values Tilray Inc's assets below their book value (0.27 x), which may indicate investor concerns about asset quality or future growth.

Significant Asset Reduction: Tilray Inc's assets decreased by 50.8% over the past year, potentially indicating divestiture, restructuring, or challenging business conditions.

Annual Total Assets for Tilray Inc (2012–2025)

The table below shows the annual total assets of Tilray Inc from 2012 to 2025.

Year Total Assets Change
2025-05-31 $2.90 Billion -50.83%
2024-05-31 $5.91 Billion -0.28%
2023-05-31 $5.92 Billion -13.77%
2022-05-31 $6.87 Billion +14.01%
2021-05-31 $6.03 Billion +404.63%
2020-05-31 $1.19 Billion +33.55%
2019-05-31 $894.03 Million +1200.48%
2018-05-31 $68.75 Million +53.08%
2017-05-31 $44.91 Million +61.44%
2016-05-31 $27.82 Million +141.87%
2015-05-31 $11.50 Million +3974.25%
2014-05-31 $282.27K 0.00%
2013-05-31 $282.27K -18.00%
2012-05-31 $344.23K --